Abstract:Abstract Background Recently, a variety of clinical trials have shown that apatinib, a small-molecule anti-angiogenic drug, exerts promising inhibitory effects on multiple solid tumors, including non-small cell lung cancer (NSCLC). However, the underlying molecular mechanism of apatinib on NSCLC remains unclear. Methods MTT, EdU, AO/EB staining, TUNEL staining, flow cytometry, colony formation assays were performed to investigate the effects of apatinib on cell proliferation, cell cycle distribution, apoptosis and cancer stem like properties. Wound healing and transwell assays were conducted to explore the role of apatinib on migration and invasion. The regulation of apatinib on VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling were detected. Furthermore, we collected conditioned medium (CM) from A549 and H1299 cells to stimulate phorbol myristate acetate (PMA)-activated THP-1 cells, and examined the effect of apatinib on PD-L1 expression in macrophages. The Jurkat T cells and NSCLC cells co-culture model was used to assess the effect of apatinib on T cells activation. Subcutaneous tumor formation models were established to evaluate the effects of apatinib in vivo. Histochemical, immunohistochemical staining and ELISA assay were used to examine the levels of signaling molecules in tumors. Results We showed that apatinib inhibited cell proliferation and promoted apoptosis in NSCLC cells in vitro. Apatinib induced cell cycle arrest at G1 phase and suppressed the expression of Cyclin D1 and CDK4. Moreover, apatinib upregulated Cleaved Caspase 3, Cleaved Caspase 9 and Bax, and downregulated Bcl-2 in NSCLC cells. The colony formation ability and the number of CD133 positive cells were significantly decreased by apatinib, suggesting that apatinib inhibited the malignant and stem-like features of NSCLC cells. Mechanistically, apatinib inhibited PD-L1 and c-Myc expression by targeting VEGFR2/STAT3 signaling. Apatinib also inhibited PD-L1 expression in THP-1 derived macrophages stimulated by CM from NSCLC cells. Furthermore, apatinib pretreatment increased CD69 expression and IFN-γ secretion in stimulated Jurkat T cells co-cultured with NSCLC cells. Apatinib also promoted ROS production and inhibited Nrf2 and p62 expression, leading to the autophagic and apoptotic cell death in NSCLC. Moreover, apatinib significantly inhibited tumor growth in vivo. Conclusion Our data indicated that apatinib induced autophagy and apoptosis in NSCLC via regulating VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling.

Latcripin-13 Domain Induces Apoptosis and Cell Cycle Arrest at the G1 Phase in Human Lung Carcinoma A549 Cells.

In Vitro Antitumor Activity Of Latcripin-15 Regulator Of Chromosome Condensation 1 Domain Protein

Expression and Functional Analysis of Novel Molecule - Latcripin-13 Domain from Lentinula Edodes C91-3 Produced in Prokaryotic Expression System

A novel apoptosis correlated molecule: expression and characterization of protein Latcripin-1 from Lentinula edodes C(91-3).

Liriopesides B Induces Apoptosis and Cell Cycle Arrest in Human Non‑small Cell Lung Cancer Cells.

Latcripin-7A, derivative of Lentinula edodes C91–3, reduces migration and induces apoptosis, autophagy, and cell cycle arrest at G1 phase in breast cancer cells

Expression and characterization of protein Latcripin-3, an antioxidant and antitumor molecule from Lentinula edodes C91-3.

Anticancer Effect of Icaritin on Human Lung Cancer Cells Through Inducing S Phase Cell Cycle Arrest and Apoptosis.

Effects of Polyphyllin I on Growth Inhibition of Human Non-Small Lung Cancer Cells and in Xenograft

Inhibition of G9a attenuates cell proliferation via the mitochondrial apoptosis pathway in lung adenocarcinoma

Peneciraistin C Induces Caspase-Independent Autophagic Cell Death Through Mitochondrial-Derived Reactive Oxygen Species Production in Lung Cancer Cells

Expression and Antitumor Function of Latcripin-4 RCC1 and ANK Domain Protein on HepG2 from the Shiitake Medicinal Mushroom, Lentinus Edodes C91-3 (agaricomycetes), Transcriptome.

Xanthatin induces cell cycle arrest at G2/M checkpoint and apoptosis via disrupting NF-κB pathway in A549 non-small-cell lung cancer cells.

Selective Activator of Human ClpP Triggers Cell Cycle Arrest to Inhibit Lung Squamous Cell Carcinoma

Ponicidin, an Ent-Kaurane Diterpenoid Derived from A Constituent of the Herbal Supplement Pc-Spes, Rabdosia Rubescens, Induces Apoptosis by Activation of Caspase-3 and Mitochondrial Events in Lung Cancer Cells in Vitro

A Novel Compound RY10-4 Induces Apoptosis and Inhibits Invasion Via Inhibiting STAT3 Through ERK-, P38-Dependent Pathways in Human Lung Adenocarcinoma A549 Cells

Xanthatin Triggers Chk1-mediated DNA Damage Response and Destabilizes Cdc25C Via Lysosomal Degradation in Lung Cancer Cells

Marchantin C, a Macrocyclic Bisbibenzyl, Induces Apoptosis of Human Glioma A172 Cells.

Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer

Glycogen Synthase Kinase 3beta Induces Cell Cycle Arrest in a Cyclin D1-dependent Manner in Human Lung Adenocarcinoma Cell Line A549.

Schisandrin B inhibits the proliferation of human lung adenocarcinoma A549 cells by inducing cycle arrest and apoptosis.